ClinVar Miner

Submissions for variant NM_000038.6(APC):c.2161_2170del (p.Gly721fs)

dbSNP: rs1554083981
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000589699 SCV000694008 pathogenic Familial multiple polyposis syndrome 2017-07-21 criteria provided, single submitter clinical testing Variant summary: The c.2161_2170delGGAAGTGCTG (p.Gly721Glnfs) variant in APC gene is a frameshift change that results in the loss of the ~2123 amino acids of APC protein (~75%). This change is predicted to cause loss of normal protein function through protein truncation or nonsense-mediated mRNA decay. The variant is absent from the large control population datasets of ExAC and gnomAD (120756 and 245146 chrs tested, respectively). The c.2161_2170delGGAAGTGCTG has not, to our knowledge, been reported in affected individuals via published reports or cited by reputable databases/clinical laboratories. Other overlapping truncated variants, such as c.2162delG and c.2169delT, have been reported in association with APC. Based on the location of this variant within exon 16, it is expected to result in classical FAP. Taken together, the variant was classified as Pathogenic.
Invitae RCV003744601 SCV002232062 pathogenic Familial adenomatous polyposis 1 2021-10-13 criteria provided, single submitter clinical testing This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have not been performed to directly test the effect on APC protein function, this suggests that disruption of the C-terminal portion of the protein is functionally important. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the APC protein in which other variant(s) (p.Tyr2645Lysfs*14) have been determined to be pathogenic (PMID: 1316610, 8381579, 9824584, 22135120, 27081525; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 495355). This variant has not been reported in the literature in individuals affected with APC-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly721Glnfs*3) in the APC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 2123 amino acid(s) of the APC protein.
Myriad Genetics, Inc. RCV001853965 SCV004045189 pathogenic Familial adenomatous polyposis 1 2023-05-04 criteria provided, single submitter clinical testing This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.